Resmed Inc DRC (RMD)

Sydney
Currency in AUD
38.810
+0.190(+0.49%)
Delayed Data·
RMD Scorecard
Full Analysis
Has raised its dividend for 13 consecutive years
RMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
38.53038.850
52 wk Range
27.13040.750
Key Statistics
Edit
Bid/Ask
38.81 / 38.82
Prev. Close
38.62
Open
38.53
Day's Range
38.53-38.85
52 wk Range
27.13-40.75
Volume
27.08K
Average Volume (3m)
1.2M
1-Year Change
21.81%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
46.109
Upside
+18.81%
Members' Sentiments
Bearish
Bullish
ProTips
7 analysts have revised their earnings upwards for the upcoming period

Resmed Inc DRC News & Analysis

Show more

Resmed Inc DRC Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN’s software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Compare RMD to Peers and Sector

Metrics to compare
RMD
Peers
Sector
Relationship
P/E Ratio
28.0x−13.6x−0.5x
PEG Ratio
0.750.010.00
Price/Book
6.6x2.9x2.6x
Price / LTM Sales
7.3x2.5x3.0x
Upside (Analyst Target)
15.2%77.7%51.9%
Fair Value Upside
Unlock−25.0%8.9%Unlock

Analyst Ratings

11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 46.109
(+18.81% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.94%
Dividend Yield
0.84%
Industry Median 1.21%
Annualized payout
0.33
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
2.48 / --
Revenue / Forecast
1.29B / --
EPS Revisions
Last 90 days

RMD Income Statement

People Also Watch

275.17
PME
+0.40%
4.03
EDV
+0.12%
1.560
PRN
0.00%
4.835
MPL
-0.31%
40.22
TNE
-0.81%

FAQ

What Is the Resmed DRC (RMD) Stock Price Today?

The Resmed DRC stock price today is 38.81

What Stock Exchange Does Resmed DRC Trade On?

Resmed DRC is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Resmed DRC?

The stock symbol for Resmed DRC is "RMD."

Does Resmed DRC Pay Dividends? What’s The Current Dividend Yield?

The Resmed DRC dividend yield is 0.84%.

What Is the Resmed DRC Market Cap?

As of today, Resmed DRC market cap is 56.74B.

What Is Resmed DRC's Earnings Per Share (TTM)?

The Resmed DRC EPS (TTM) is 8.94.

From a Technical Analysis Perspective, Is RMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Resmed DRC Stock Split?

Resmed DRC has split 3 times.

How Many Employees Does Resmed DRC Have?

Resmed DRC has 9980 employees.

What is the current trading status of Resmed DRC (RMD)?

As of Jun 20, 2025, Resmed DRC (RMD) is trading at a price of 38.81, with a previous close of 38.62. The stock has fluctuated within a day range of 38.53 to 38.85, while its 52-week range spans from 27.13 to 40.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.